Combined hepatocellular carcinoma-cholangiocarcinoma: Report of MR appearance in eleven patients

被引:41
|
作者
de Campos, Rafael O. P. [1 ]
Semelka, Richard C. [1 ]
Azevedo, Rafael M. [1 ]
Ramalho, Miguel [1 ]
Heredia, Vasco [1 ]
Armao, Diane M. [1 ,2 ]
Woosley, John T. [2 ]
机构
[1] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA
关键词
combined hepatocellular-cholangiocarcinoma; mixed; magnetic resonance findings; MR appearance; primary liver tumor; INTRAHEPATIC CHOLANGIOCARCINOMA; COMPUTED-TOMOGRAPHY; PROGNOSTIC-FACTORS; CT; LIVER; TRANSPLANTATION; METASTASES; PATTERNS; FEATURES;
D O I
10.1002/jmri.23754
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To describe the magnetic resonance imaging (MRI) appearance of hepatic combined hepatocellular-cholangiocarcinoma (cHCC-CC) in 11 patients. Materials and Methods: The database of the Department of Pathology was cross-referenced with the MRI database to identify patients with confirmed cHCC-CC who had undergone MRI. Eleven consecutive patients were included (seven female, mean age 57.6 years). All patients were Caucasian. Five of 11 had a clinical history of chronic liver disease. Two radiologists retrospectively analyzed the images in consensus. Results: cHCC-CC was a single mass in 10/11 patients. Margins were well-defined in 6/11. All tumors showed heterogeneous hyperintensity on T2. On postcontrast imaging, 6/11 showed early ring-enhancement (four noncirrhotic), with progressive enhancement in central portions, and 5/11 patients showed a diffuse heterogeneous early enhancement. Three of these five were cirrhotic and displayed partial washout with portions of contrast retention on later phases. Other findings included: late capsule enhancement (two patients), biliary dilatation (one), venous invasion (three), lymphadenopathy (six), and findings of cirrhosis (five). Conclusion: cHCC-CC presents most commonly as a single mass. Five of 11 had MR findings of cirrhosis. Clues to the diagnosis were moderately high signal on T2, portions of tumor that show progressive enhancement/contrast retention, and frequent lack of capsule. Early enhancement patterns included early ring-enhancement and diffuse heterogeneous enhancement. J. Magn. Reson. Imaging 2012;36:11391147. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:1139 / 1147
页数:9
相关论文
共 50 条
  • [21] Combined hepatocellular carcinoma-cholangiocarcinoma with sarcomatoid features: new insights into a rare and aggressive tumor
    Ghaffar, Sumaya Abdul
    Ishida, Aline Hikari
    Gleisner, Ana Luiza
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (06) : 2748 - 2750
  • [22] How to differentiate between combined hepatocellular carcinoma-cholangiocarcinoma and intrahepatic cholangiocarcinoma with rim arterial phase hyperenhancement?
    Zhou, Changwu
    Huang, Peng
    Wu, Fei
    Xiao, Yuyao
    Yang, Chun
    Zeng, Mengsu
    ABDOMINAL RADIOLOGY, 2024, 49 (09) : 3015 - 3023
  • [23] Component prediction in combined hepatocellular carcinoma-cholangiocarcinoma: habitat imaging and its biologic underpinnings
    Xiao, Yuyao
    Huang, Peng
    Zhang, Yunfei
    Lu, Xin
    Zhou, Changwu
    Wu, Fei
    Wang, Yi
    Zeng, Mengsu
    Yang, Chun
    ABDOMINAL RADIOLOGY, 2024, 49 (04) : 1063 - 1073
  • [24] Survival outcomes of combined hepatocellular carcinoma-cholangiocarcinoma following liver resection and liver transplantation
    Jwa, Eunkyoung
    Hwang, Shin
    Ahn, Chul-Soo
    Ha, Tae-Yong
    Park, Gil-Chun
    Sung, Min-Kyu
    Kim, Jee-Yeon
    Lee, Sung-Gyu
    TRANSPLANTATION, 2016, 100 (07) : S502 - S502
  • [25] Survival Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma Following Liver Resection and Liver Transplantation
    Jwa, Eunkyoung
    Hwang, Shin
    Kim, Ki-Hun
    Ahn, Chul-Soo
    Moon, Deok-Bog
    Ha, Tae-Yong
    Song, Gi-Won
    Jung, Dong-Hwan
    Lee, Sung-Gyu
    TRANSPLANTATION, 2016, 100 : S233 - S233
  • [26] Component prediction in combined hepatocellular carcinoma-cholangiocarcinoma: habitat imaging and its biologic underpinnings
    Yuyao Xiao
    Peng Huang
    Yunfei Zhang
    Xin Lu
    Changwu Zhou
    Fei Wu
    Yi Wang
    Mengsu Zeng
    Chun Yang
    Abdominal Radiology, 2024, 49 : 1063 - 1073
  • [27] Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors
    Dageforde, Leigh Anne
    Vachharajani, Neeta
    Tabrizian, Parissa
    Agopian, Vatche
    Halazun, Karim
    Maynard, Erin
    Croome, Kristopher
    Nagorney, David
    Hong, Johnny C.
    Lee, David
    Ferrone, Cristina
    Baker, Erin
    Jarnagin, William
    Hemming, Alan
    Schnickel, Gabriel
    Kimura, Shoko
    Busuttil, Ronald
    Lindemann, Jessica
    Florman, Sander
    Holzner, Matthew L.
    Srouji, Rami
    Najjar, Marc
    Yohanathan, Lavanya
    Cheng, Jane
    Amin, Hiral
    Rickert, Charles A.
    Yang, Ju Dong
    Kim, Joohyun
    Pasko, Jennifer
    Chapman, William C.
    Doyle, Maria B. Majella
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 232 (04) : 361 - 371
  • [28] Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification
    Dong-Hwan Jung
    Shin Hwang
    Seung-Mo Hong
    Yong-Kyu Chung
    Gi-Won Song
    Young-Joo Lee
    Ki-Hun Kim
    Chul-Soo Ahn
    Deok-Bog Moon
    Tae-Yong Ha
    Gil-Chun Park
    Han Chu Lee
    Young-Suk Lim
    Eun Sil Yu
    Sung-Gyu Lee
    World Journal of Surgery, 2017, 41 : 1347 - 1357
  • [29] Characterization of outcomes and genomic alterations (GA) in combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA).
    Haro-Silerio, Jaime
    Fox, Daniel Aaron
    Bhamidipati, Deepak
    Hu, Zishuo Ian
    Koay, Eugene Jon
    Ludmir, Ethan B.
    Cao, Hop Sanderson Tran
    Vauthey, Jean-Nicolas
    Newhook, Timothy E.
    Tzeng, Ching-Wei D.
    Chun, Yun Shin
    Mahvash, Armeen
    Metwalli, Zeyad
    Habibollahi, Peiman
    Cox, Veronica L.
    Kang, Hyunseon
    Chatterjee, Deyali
    Kaseb, Ahmed Omar
    Javle, Milind M.
    Lee, Sunyoung S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 458 - 458
  • [30] Context-Dependent Distinct Roles of SOX9 in Combined Hepatocellular Carcinoma-Cholangiocarcinoma
    Park, Yoojeong
    Hu, Shikai
    Kim, Minwook
    Oertel, Michael
    Singhi, Aatur
    Monga, Satdarshan P.
    Liu, Silvia
    Ko, Sungjin
    CELLS, 2024, 13 (17)